scholarly journals Maternal serum concentrations of perfluoroalkyl substances during pregnancy and gestational weight gain: The Avon Longitudinal Study of Parents and Children

2019 ◽  
Vol 90 ◽  
pp. 8-14 ◽  
Author(s):  
Kristin J. Marks ◽  
Zuha Jeddy ◽  
W. Dana Flanders ◽  
Kate Northstone ◽  
Abigail Fraser ◽  
...  
BMC Nutrition ◽  
2021 ◽  
Vol 7 (1) ◽  
Author(s):  
Ahlia Sekkarie ◽  
Jean A. Welsh ◽  
Kate Northstone ◽  
Aryeh D. Stein ◽  
Usha Ramakrishnan ◽  
...  

Abstract Background Priming for cardiometabolic diseases, including non-alcoholic fatty liver disease (NAFLD), is hypothesized to begin in utero. The primary objective of this study is to determine whether there is an association between maternal nutritional status and offspring NAFLD. Methods Data come from the Avon Longitudinal Study of Parents and Children (ALSPAC) in the UK. The analytic sample included 3353 participants who had maternal information on pre-pregnancy BMI, gestational weight gain, diabetes, and free sugar intake as percent of total energy and were assessed for mild-severe hepatic steatosis at 24 years by transient elastography (controlled attenuation parameter score ≥ 248 dB/m). Multiple logistic regression was used to evaluate the association between maternal factors and offspring hepatic steatosis at 24 years. Results In confounder-adjusted models the independent associations for each maternal factor with mild to severe vs low hepatic steatosis at 24 years were: pre-pregnancy overweight (OR: 1.84, 95%CL: 1.43–2.38) or obesity (OR: 2.73, 95%CL: 1.84–4.03), more than recommended gestational weight gain (OR: 1.30, 95%CL: 1.04–1.64), diabetes (OR: 1.39, 95%CI: 0.87, 2.21), and high free sugar intake during pregnancy (OR: 1.04, 95% CI: 0.82, 1.33). These associations were largely mediated by BMI at 24 years, but not by birthweight or breastfeeding. Conclusions Our results suggest that maternal nutritional status is associated with the development of NAFLD in their adult offspring, although the relationship is largely mediated by offspring BMI in adulthood.


2016 ◽  
Vol 30 (1) ◽  
pp. 51-58 ◽  
Author(s):  
S. P. Mourtakos ◽  
K. D. Tambalis ◽  
D. B. Panagiotakos ◽  
G. Antonogeorgos ◽  
C. D. Alexi ◽  
...  

2020 ◽  
Vol 20 (1) ◽  
Author(s):  
Roger Figueroa ◽  
Jaclyn A. Saltzman ◽  
Augustine Kang ◽  
Fernanda Neri Mini ◽  
Kirsten K. Davison ◽  
...  

Appetite ◽  
2014 ◽  
Vol 83 ◽  
pp. 304-308 ◽  
Author(s):  
Carla L. van der Wijden ◽  
Stefanie Steinbach ◽  
Hidde P. van der Ploeg ◽  
Willem van Mechelen ◽  
Mireille N.M. van Poppel

Author(s):  
Kathleen M. Antony ◽  
Mona Romezi ◽  
Kourtnee Lindgren ◽  
Kristen B. Mitchell ◽  
Susan F. Venable ◽  
...  

Abstract Objective The purpose of this study was to evaluate the independent contribution of maternal obesity and gestational weight gain (GWG) in excess of the Institute of Medicine's guidelines on levels of maternal serum inflammatory and metabolic measures. Study Design Banked maternal serum samples from 120 subjects with documented prepregnancy or first trimester body mass index (BMI) were utilized for analyte analyses. Validated, BMI-specific formulas were utilized to categorize GWG as either insufficient, at goal or excess based on the Institute of Medicine guidelines with gestational age adjustments. Serum was analyzed for known inflammatory or metabolic pathway intermediates using the Luminex xMap system with the MILLIPLEX Human Metabolic Hormone Magnetic Bead Panel. Measured analytes included interleukin-6, monocyte chemoattractant protein-1, and tumor necrosis factor-α and metabolic markers amylin, c-peptide, ghrelin, gastric inhibitory polypeptide, glucagon-like peptide-1, glucagon, insulin, leptin, pancreatic polypeptide, and peptide YY. Kruskal–Wallis ANOVA and Pearson's correlation coefficients were calculated for each marker. Results C-peptide, insulin, and leptin all varied significantly with both obesity and GWG while glucagon-like peptide-1 varied by BMI but not GWG. These analytes covaried with other metabolic analytes, but not with inflammatory analytes. Conclusion Maternal metabolic biomarkers at delivery vary significantly with both obesity and GWG. Taken together, these findings suggest that GWG (with and without comorbid obesity) is an important mediator of measurable metabolites in pregnancy but is not necessarily accompanied by inflammatory measures in serum. These findings are consistent with GWG being an independent risk factor for metabolic disturbances during pregnancy.


Sign in / Sign up

Export Citation Format

Share Document